MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells

RSC Advances ◽

10.1039/c8ra10224d ◽

2019 ◽

Vol 9 (37) ◽

pp. 21139-21146

Author(s):

Guimin Chen ◽

Lei Ye ◽

Yufei Han ◽

Ping Han

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

T790m Mutation ◽

MiR-148a inhibits NSCLC progression.

Download Full-text

Retraction: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells

RSC Advances ◽

10.1039/d1ra90049h ◽

2021 ◽

Vol 11 (9) ◽

pp. 5265-5265

Author(s):

Laura Fisher

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

T790m Mutation ◽

Retraction of ‘MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells’ by Guimin Chen et al., RSC Adv., 2019, 9, 21139–21146, DOI: 10.1039/C8RA10224D.

Download Full-text

Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation

10.18632/oncotarget.3332 ◽

2015 ◽

Vol 6 (8) ◽

pp. 5832-5845 ◽

Author(s):

Shirong Zhang ◽

Xiaoliang Zheng ◽

Haixiu Huang ◽

Kan Wu ◽

Bing Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

T790m Mutation ◽

Download Full-text

Combined Treatment withEpimedium koreanumNakai Extract and Gefitinib Overcomes Drug Resistance Caused by T790M Mutation in Non-Small Cell Lung Cancer Cells

Nutrition and Cancer ◽

10.1080/01635581.2014.895392 ◽

2014 ◽

Vol 66 (4) ◽

pp. 682-689 ◽

Author(s):

Jie Song ◽

Rongling Zhong ◽

Houcai Huang ◽

Zhenhai Zhang ◽

Dongmei Ding ◽

...

Keyword(s):

Lung Cancer ◽

Drug Resistance ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Combined Treatment ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

Download Full-text

Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2018.06.065 ◽

2018 ◽

Vol 503 (2) ◽

pp. 710-714

Author(s):

Sujin Kim ◽

Angela KJ. Park ◽

Jeonghee Cho

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

De Novo ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

Early Emergence ◽

Download Full-text

Abstract 4149: Increased migration ability of osimertinib-resistant EGFR-T790M mutant non-small-cell lung cancer cells

10.1158/1538-7445.am2017-4149 ◽

2017 ◽

Author(s):

Satoshi Kambayashi ◽

Yasuhiro Koh ◽

Maiha Ohyama ◽

Ayaka Tanaka ◽

Hiroaki Akamatsu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

Migration Ability ◽

Download Full-text

Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181d95d93 ◽

2010 ◽

Vol 5 (6) ◽

pp. 765-777 ◽

Author(s):

Flavia F. Moreira-Leite ◽

Luke R. Harrison ◽

Alexandr Mironov ◽

Ruth A. Roberts ◽

Caroline Dive

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

Gefitinib Resistance ◽

Download Full-text

P8‐21: Heterogeneity among tumors with acquired resistance to EGFR‐TKIs harboring EGFR‐T790M mutation in non‐small cell lung cancer cells

Respirology ◽

10.1111/resp.14150_533 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 295-295

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Acquired Resistance ◽

Small Cell Lung ◽

T790m Mutation ◽

Download Full-text

Faculty Opinions recommendation of Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733460129.793580846 ◽

2020 ◽

Author(s):

Leonardo Salmena

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Pyruvate Kinase ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung ◽

Down Regulation ◽

Download Full-text

Paeonol Inhibits Migration, Invasion and Bone Adhesion of Small Cell Lung Cancer Cells

Current Signal Transduction Therapy ◽

10.2174/1574362410666150625191130 ◽

2015 ◽

Vol 10 (2) ◽

pp. 126-130

Author(s):

Yong Tian ◽

Cong Chen ◽

Yu Zhang ◽

Zhen Zhang ◽

Haiyan Xie

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

Small Cell Lung

Download Full-text

CircZNF208 enhances the sensitivity to X-rays instead of carbon-ions through the miR-7-5p /SNCA signal axis in non-small-cell lung cancer cells

Cellular Signalling ◽

10.1016/j.cellsig.2021.110012 ◽

2021 ◽

pp. 110012

Author(s):

Bingtao Liu ◽

Hongbin Li ◽

Xiongxiong Liu ◽

Feifei Li ◽

Weiqiang Chen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Lung Cancer Cells ◽

X Rays ◽

Carbon Ions ◽

Small Cell Lung

Download Full-text